J&J Offers $5.5bn to Settle Baby Powder Suits

Pharmaceutical giant Johnson and Johnson has put forward a proposed settlement of up to $5.5 billion to resolve thousands of lawsuits alleging that its talc-based baby powder products caused cancer, particularly ovarian cancer and mesothelioma. The offer is designed to bring closure to one of the most protracted consumer product liability cases in US legal history.

Years of Legal Battle

J&J has faced litigation from tens of thousands of plaintiffs over its talcum powder products for more than a decade. Claimants allege that the company knew about the presence of asbestos in its talc and failed to warn consumers of potential health risks. J&J has consistently denied that its products were unsafe.

The company previously attempted to resolve the lawsuits through bankruptcy proceedings, a strategy that courts ultimately rejected. This latest settlement offer represents a shift toward direct resolution.

What the Deal Covers

If accepted, the $5.5 billion settlement would be distributed among eligible claimants, covering individuals diagnosed with certain cancers they attribute to long-term talcum powder use. The exact distribution terms are still being negotiated.

This proposed settlement represents our commitment to providing certainty and closure for those who have been affected, J&J said in a statement.

Industry Implications

The resolution of this case will have broader implications for the consumer products industry and product liability law. It underscores the financial risks companies face when safety concerns about widely used products emerge over time.